RecallRadar

FDA Drug recall D-0127-2024

Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North…

On 2023-12-06 the FDA classified a Class III recall of Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North… by Teva Pharmaceuticals Usa, citing OOS for viscosity.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0127-2024
ClassificationClass III
Statusterminated
Initiated2023-11-10
Published2023-12-06
Last updated2026-09-13 11:52 UTC
CompanyTeva Pharmaceuticals Usa
DistributionUS

Product

Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30

Reason

OOS for viscosity

Identifiers

ndc0591-2924-18
ndc0591-2925-32
ndc0591-2925-30
ndc0591-2926-25
ndc0591-2926-30
code_infoLot #: 100029472, Exp. 2/29/2024

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0127-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.